Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Basic and clinical studies on clarithromycin in pediatrics].

N Iwai1, Y Taneda, M Miyazu

  • 1Department of Pediatrics, Meitetsu Hospital.

The Japanese Journal of Antibiotics
|February 1, 1989
PubMed
Summary

Clarithromycin (TE-031) pediatric studies show it maintains high blood concentrations and is efficiently excreted. Bioavailability is slightly better when taken on an empty stomach, with granular and tablet forms showing equivalent absorption and excretion.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Semidiscoid lateral meniscus].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·1992
Same author

[Abnormal chest shadow on CT in immunosuppressed patients].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·1992
Same author

[MR imaging evaluation of plica synoviallis mediopatellaris of the knee joint].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·1992
Same author

Structure-activity relationships of mu-conotoxin GIIIA: structure determination of active and inactive sodium channel blocker peptides by NMR and simulated annealing calculations.

Biochemistry·1992
Same author

Tumor necrosis factor modulation of expression of the cystic fibrosis transmembrane conductance regulator gene.

FEBS letters·1992
Same author

Inhibition of passive cutaneous anaphylaxis by synthetic human immunoglobulin E peptide fragments.

FEBS letters·1992

Area of Science:

  • Pharmacology
  • Pediatric Medicine
  • Antibiotic Research

Background:

  • Clarithromycin (TE-031) is a novel macrolide antibiotic developed for pediatric use.
  • Studies evaluated pediatric pharmacokinetic profiles of granular and 50 mg tablet formulations.

Observation:

  • Serum concentrations, urinary excretion, and half-life were assessed in children following oral administration.
  • Administration timing (pre-meal vs. post-meal) and formulation type (granular vs. tablet) were investigated.

Findings:

  • TE-031 demonstrated sustained high serum concentrations and efficient urinary excretion compared to conventional macrolides.
  • Preprandial administration resulted in slightly superior bioavailability, with peak serum concentrations occurring earlier.
  • Granular and 50 mg tablet formulations exhibited comparable absorption and excretion profiles.

Related Experiment Videos

Implications:

  • TE-031 offers a promising pharmacokinetic profile for pediatric infections.
  • Administration guidelines should consider preprandial dosing for potentially enhanced efficacy.
  • The equivalence of different formulations simplifies pediatric dosing regimens.